Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00790569 · OUTCOME

Carbon Monoxide (CO)-Confirmed 7-day Abstinence

Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking · Source last updated 2018-06-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
6-Months

What was measured

Number of participants reporting 7-day abstinence at 6-months, confirmed with CO measurement.

Groups in this outcome

Arm I

Patients receive oral varenicline once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. varenicline: Given orally

Arm II

Patients receive oral varenicline placebo once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. placebo: Given orally

Arm III

Patients receive a nicotine patch, with doses tapering over time for a total of 26 weeks. Patients also receive nicotine gum to quell breakthrough urges. Patients may stop treatment when a comfortable level of smoking abstinence is reached. nicotine: Given transdermally and orally

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I137
Arm II45
Arm III133

Reported measurements

Source class 1
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm I5Not reportedNot reportedNot reportedNot reported
Arm II1Not reportedNot reportedNot reportedNot reported
Arm III11Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        5
      2. group Id
        OG001
        value
        1
      3. group Id
        OG002
        value
        11
denoms
  1. counts
    1. group Id
      OG000
      value
      137
    2. group Id
      OG001
      value
      45
    3. group Id
      OG002
      value
      133
    units
    Participants
description
Number of participants reporting 7-day abstinence at 6-months, confirmed with CO measurement.
groups
  1. description
    Patients receive oral varenicline once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. varenicline: Given orally
    id
    OG000
    title
    Arm I
  2. description
    Patients receive oral varenicline placebo once daily on days 1-3 and twice daily thereafter for a total of 6 months or when a comfortable level of smoking abstinence is reached. placebo: Given orally
    id
    OG001
    title
    Arm II
  3. description
    Patients receive a nicotine patch, with doses tapering over time for a total of 26 weeks. Patients also receive nicotine gum to quell breakthrough urges. Patients may stop treatment when a comfortable level of smoking abstinence is reached. nicotine: Given transdermally and orally
    id
    OG002
    title
    Arm III
param Type
NUMBER
reporting Status
POSTED
time Frame
6-Months
title
Carbon Monoxide (CO)-Confirmed 7-day Abstinence
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice